Serum Seralite®– Free Light Chain (FLC). Seralite®

27 June 2016

Announcement has been made that Sebia will partner with Abingdon Health in been the global distribution of Serum Seralite®– Free Light Chain (FLC). Seralite®– FLC is the most recent generation of rapid, smart and easy-to-operate test for the quantitative measurement of free kappa and free lambda light chains in blood. Serum free light chain (sFLC) testing is prescribed to help detect, diagnose and monitor plasma cell disorders (dyscrasias) such as multiple myeloma, and to monitor the effectiveness of treatments. 

For more information do visit http://www.sebia.com/en-EN/article/seralite-flc-dual-kappalambda

Back to announcements